title: Impact of meningococcal C conjugate vaccine use in Australia.
authors.forename: Robert
authors.initials: R
authors.lastname: Booy
authors.forename: Jane
authors.initials: J
authors.lastname: Jelfs
authors.forename: Haitham
authors.initials: H
authors.lastname: El Bashir
authors.forename: Michael D
authors.initials: MD
authors.lastname: Nissen
mesh_terms: D000293:Adolescent; D000328:Adult; D001315:Australia / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D038541:Neisseria meningitidis, Serogroup B; D038542:Neisseria meningitidis, Serogroup C; D006113:United Kingdom
chemical_list: D022401:Meningococcal Vaccines; C410218:serogroup C meningococcal conjugate vaccine